Number of the records: 1
Prevention and therapy of chemotherapy-induced peripheral neuropathy: a review of recent findings
Title Prevention and therapy of chemotherapy-induced peripheral neuropathy: a review of recent findings Author Michalová Zuzana 1992 SAVNEBIO - Neurobiologický ústav SAV SCOPUS RID ORCID Co-authors Székiová Eva 1970 SAVNEBIO - Neurobiologický ústav SAV SCOPUS RID ORCID Blaško Juraj 1982 SAVNEBIO - Neurobiologický ústav SAV SCOPUS RID ORCID Vanický Ivo 1962 SAVNEBIO - Neurobiologický ústav SAV ORCID Source document Neoplasma. Vol.70 , no.1 (2022), p. 15-35 Language eng - English Country SK - Slovak Republic Document kind rozpis článkov z periodík (rbx) Citations AHMED, L.A. - AL-MASSRI, K.F. Exploring the Role of Mesenchymal Stem Cell-Derived Exosomes in Diabetic and Chemotherapy-Induced Peripheral Neuropathy. In MOLECULAR NEUROBIOLOGY. ISSN 0893-7648, 2024 JAN 22 2024. Dostupné na: https://doi.org/10.1007/s12035-024-03916-z. DA-SILVA, O.F. - ADELOWO, A.R. - BABALOLA, A.A. - IKEJI, C.N. - OWOEYE, O. - ROCHA, J.B.T. - ADEDARA, I.A. - FAROMBI, E.O. Diphenyl Diselenide Through Reduction of Inflammation, Oxidative Injury and Caspase-3 Activation Abates Doxorubicin-Induced Neurotoxicity in Rats. In NEUROCHEMICAL RESEARCH. ISSN 0364-3190, 2024 JAN 24 2024. Dostupné na: https://doi.org/10.1007/s11064-023-04098-1. ERMIS, Okan - AKÇALI, Didem Tuba. Chemotherapy-Induced Peripheral Neuropathy and Treatment. In Anestezi Dergisi, 2023-01-01, 31, 2, pp. 109-117. ISSN 13000578. Dostupné na: https://doi.org/10.54875/jarss.2023.06977. Category ADDA - Scientific papers in domestic journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2023 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.4149/neo_2022_221007N992 article
File name Access Size Downloaded Type License Prevention and therapy of chemotherapy-induced peripheral neuropathy a review of recent findings.pdf available 484.9 KB 0 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2022 2021 3.409 Q3 0.580 Q2
Number of the records: 1